OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fueling HCC Dynamics: Interplay Between Tumor Microenvironment and Tumor Initiating Cells
Hongyang Huang, Yu‐Man Tsui, Irene Oi‐Lin Ng
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 5, pp. 1105-1116
Open Access | Times Cited: 13

Showing 13 citing articles:

MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function
Zhipeng Li, Huaxin Zhou, Xiangyu Zhai, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 11
Open Access | Times Cited: 37

γδ T Cells: A Game Changer in the Future of Hepatocellular Carcinoma Immunotherapy
Stavros P. Papadakos, Konstantinos Arvanitakis, Ioanna Ε. Stergiou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1381-1381
Open Access | Times Cited: 7

Collagen XVII promotes dormancy of colorectal cancer cells by activating mTORC2 signaling
Jinlong Lin, Bingxu Zou, Hongbo Li, et al.
Cellular Signalling (2024) Vol. 120, pp. 111234-111234
Closed Access | Times Cited: 6

Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy
Bemrew Admassu Mengistu, Tirunesh Tsegaw, Yitayew Demessie, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6

Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications
Mario Romeo, Marcello Dallio, Flavia Scognamiglio, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5178-5178
Open Access | Times Cited: 12

Sorafenib and Treg Differentiation: A Paradigm Shift in Hepatocellular Carcinoma Management
Hanyang Liu
Cellular and Molecular Gastroenterology and Hepatology (2025), pp. 101478-101478
Open Access

The immunosuppressive role of MDSCs in HCC: mechanisms and therapeutic opportunities
Xiling Liu, Xichun Kang, Haiyan Kang, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access

The Role of Metabolic Reprogramming in the Tumor Immune Microenvironment: Mechanisms and Opportunities for Immunotherapy in Hepatocellular Carcinoma
Nan Hu, Haiyang Li, Changcheng Tao, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5584-5584
Open Access | Times Cited: 3

AKR1B10 inhibits the proliferation and metastasis of hepatocellular carcinoma cells by regulating the PI3K/AKT pathway
Ke Tian, Ying Deng, Zhipeng Li, et al.
Oncology Letters (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 7

An integrated investigation of sulfotransferases (SULTs) in hepatocellular carcinoma and identification of the role of SULT2A1 on stemness
Hao Peng, Kun Feng, Weilu Jia, et al.
APOPTOSIS (2024) Vol. 29, Iss. 5-6, pp. 898-919
Closed Access

Recent Advances in Immune-based Therapy for Hepatocellular Carcinoma
Kyung Won Park, Tae Hoon Park, Eun Ji Jang, et al.
Journal of Digestive Cancer Research (2024) Vol. 12, Iss. 2, pp. 115-130
Open Access

Scutellaria baicalensis and its flavonoids in the treatment of digestive system tumors
Kangning Zhao, Jinlong Zhang, Lin Zhou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access

Unveiling key drivers of hepatocellular carcinoma: a synergistic approach with network pharmacology, machine learning-driven ligand discovery and dynamic simulations
Deema Kamal Sabir, Jawaher Abdullah Bin Jumah, Ancy Iruthayaraj
SAR and QSAR in environmental research (2024) Vol. 35, Iss. 11, pp. 1045-1070
Closed Access

Page 1

Scroll to top